Urea, fluorofamide, and omeprazole treatments alter Helicobacter colonization in the mouse gastric mucosa

Helicobacter

Volumn 11, Issue 5, 2006, Pages 460-468

  Aristoteli, Lina Panayiota ^a,c   O'Rourke, Jani L ^a   Danon, Stephen ^a,d   Larsson, Hakan ^b   Mellgard, Bjorn ^b   Mitchell, Hazel ^a   Lee, Adrian ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ASTRAZENECA R AND D   (Sweden)

^c MACQUARIE UNIVERSITY   (Australia)

^d CSIRO   (Australia)

Author keywords

Animal model; Fluorofamide; Helicobacter; Urease

Indexed keywords

FLUOROFAMIDE; OMEPRAZOLE; UNCLASSIFIED DRUG; UREA; UREASE; UREASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GASTRITIS; HELICOBACTER FELIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH ACID; STOMACH ANTRUM; STOMACH MUCOSA;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BENZAMIDES; ENZYME INHIBITORS; FEMALE; GASTRIC MUCOSA; HELICOBACTER FELIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HYDROGEN-ION CONCENTRATION; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; OMEPRAZOLE; UREA; UREASE;

ANIMALIA; BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER FELIS; HELICOBACTER PYLORI;

EID: 33748458097     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2006.00439.x     Document Type: Article

References (33)

1. Smith KL, Parsonnet J. Helicobacter pylori. In Evans AS, Brachman PS, eds. Bacterial Infections of Humans: Epidemiology and Control, 3rd edn. New York: Plenum Publishing, 1998;337-53.
2. Bauerfeind P, Garner R, Dunn BE, Mobley HLT. Synthesis and activity of Helicobacter pylori urease and catalase at low pH. Gut 1997;40:25-30.
3. Clyne M, Labigne A, Drumm B. Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect Immun 1995;63:1669-73.
4. Rektorschek M, Weeks D, Sachs G, Melchers K. Influence of pH on metabolism and urease activity of Helicobacter pylori. Gastroenterology 1998;115:628-41.
5. Stingl K, Uhlemann E-M, Deckers-Hebestreit G, Schmid R, Bakker EP, Altendorf K. Prolonged survival and cytoplasmic pH homeostasis of Helicobacter pylori at pH 1. Infect Immun 2001;69:1178-81.
6. Stingl K, Uhlemann E-M, Schmid R, Altendorf K, Bakker EP. Energetics of Helicobacter pylori and its implications for the mechanism of urease-dependent acid tolerance at pH 1. Infect Immun 2002;184:3053-60.
7. Scott DR, Weeks D, Hong C, Postius S, Melchers K, Sachs G. The role of internal urease in acid resistance of Helicobacter pylori. Gastroenterology 1998;114:58-70.
8. Sachs G, Scott D, Weeks D, Melchers K. The compartment buffered by the urease of Helicobacter pylori: cytoplasm or periplasm? Trends Microbiol 2002;10:217-8.
9. Stingl K, Altendorf K, Bakker EP. The compartment buffered by the urease of Helicobacter pylori: cytoplasm or periplasm? Response Trends Microbiol 2002;10:218-9.
10. Athmann C, Zeng N, Kang T et al. Local pH elevation mediated by the intrabacterial urease of Helicobacter pylori cocultured with gastric cells. J Clin Invest 2000;106:339-47.
11. Marshall BJ, Barrett LJ, Prakash C, McCallum RW, Guerrant RL. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effects of acid. Gastroenterology 1990;99:697-702.
12. Bury-Moné S, Skouloubris S, Labigne A, De Reuse H. The Helicobacter pylori UreI protein: role in adaptation to acidity and identification of residues essential for its activity and for acid activation. Mol Microbiol 2001;42:1021-34.
13. Eaton KA, Brooks CL, Morgan DR, Krakowka S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991;59:2470-5.
14. Skouloubris S, Thiberge J-M, Labigne A, De Reuse H. The Helicobacter pylori UreI protein is not involved in urease activity but is essential for bacterial survival in vivo. Infect Immun 1998;66:4517-21.
15. Eaton KA, Gilbert JV, Joyce EA et al. In vivo complementation of ureB restores the ability of Helicobacter pylori to colonise. Infect Immun 2002;70:771-8.
16. Danon SJ, O'Rourke JL, Moss ND, Lee A. The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology 1995;108:1386-95.
17. Lee A, Mellgård B, Larsson H. Effect of gastric acid on Helicobacter pylori ecology. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori: Basic Mechanisms to Clinical Cure 1996. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1996;50-63.
18. Veldhuyzen Van Zanten SJO, Dixon MF, Lee A. The gastric transitional zones: neglected links between gastroduodenal pathology and Helicobacter ecology. Gastroenterology 1999;116:1217-29.
19. Lee A, Hazell SL, O'Rourke J, Kouprach S. Isolation of a spiral-shaped bacterium from the cat stomach. Infect Immun 1988;56:2843-50.
20. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardised mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997;112:1386-97.
21. Pope AJ, Toseland N, Rushant B, Richardson S, McVey M, Hills J. Effect of potent urease inhibitor, fluorofamide on Helicobacter sp. in vivo and in vitro. Dig Dis Sci 1998;43:109-19.
22. Larsson H, Carlsson E, Ryberg B, Fryklund J, Wallmark B. Rat parietal cell function after prolonged inhibition of gastric acid secretion. Am J Physiol 1988;254:G33-G39.
23. Dixon MF, Genta RM, Yardley JH, Correa P, Participants in the International Workshop on the Histopathology of Gastritis H. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996;20:1161-81.
24. van Zanten SJOV, Kolesnikow T, Leung V, O'Rourke JL, Lee A. Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model. Antimicrob Agents Chemother 2003;47:2249-55.
25. Hochberg Y, Benjamini Y. More powerful procedure for multiple significant testing. Stat Med 1990;9:811-8.
26. Chittajallu RS, Neithercut WD, Macdonald AMI, McColl KEL. Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin levels. Gut 1991;32:21-4.
27. Triebling AT, Korsten MA, Dlugosz JW, Paonetto F, Lieber CS. Severity of Helicobacter-induced gastric injury correlates with gastric juice ammonia. Dig Dis Sci 1991;36:1089-96.
28. El Nujumi AM, Rowe PA, Dahill S, Dorrian CA, Neithercut WD, McColl KEL. Role of ammonia in the pathogenesis of the gastritis, hypergastrinaemia, and hyperpepsinogenaemia I caused by Helicobacter pylori infection. Gut 1992;33:1612-6.
29. Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995;36:12-6.
30. Kuipers EJ, Uyterlinde AM, Peña S et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long term safety. Am J Gastroenterol 1995;90:1401-6.
31. Sjöström JE, Larsson H. Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and urease-deficient mutant. J Med Microbiol 1996;44:425-33.
32. El Nujumi AM, Dorrian CA, Chittajallu RS, Neithercut WD, McColl KEL. Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer patients. Gut 1991;32:866-70.
33. Gootz TD, Perez-Perez GI, Clancy J, Martin B-A, Tait-Kamradt A, Blaser MJ. Immunological and molecular characterisation of Helicobacter felis urease. Infect Immun 1994;62:793-8.